About Biomx ltd
Biomx Ltd: Revolutionizing the Fight Against Chronic Diseases with Natural and Engineered Phage Therapies
Biomx Ltd is a biotechnology company that is dedicated to developing natural and engineered phage therapies to eradicate harmful bacteria in chronic diseases. The company was founded in 2015 by a team of experienced scientists who recognized the potential of phages as a powerful tool for fighting bacterial infections.
Phages, or bacteriophages, are viruses that infect and kill bacteria. They are naturally occurring and have been used for decades in Eastern Europe as an alternative to antibiotics. However, their use has been limited due to the lack of understanding about their mechanisms of action and the difficulty in isolating specific phages that target specific bacteria.
Biomx Ltd is changing this by using cutting-edge technology to identify and isolate phages that target specific bacterial strains. The company's proprietary platform combines bioinformatics, genomics, and synthetic biology to create customized phage cocktails that can effectively treat chronic diseases caused by harmful bacteria.
One of Biomx's main areas of focus is on inflammatory bowel disease (IBD), which affects millions of people worldwide. IBD is caused by an imbalance in gut microbiota, which leads to chronic inflammation in the digestive tract. Antibiotics are often used to treat IBD, but they can also disrupt the balance of gut microbiota even further.
Biomx's approach is different. By using natural or engineered phage therapies specifically designed for each patient's unique microbiome profile, Biomx aims to restore balance without disrupting healthy gut flora. This personalized approach has shown promising results in preclinical studies and clinical trials are currently underway.
In addition to IBD, Biomx is also exploring other applications for its technology platform such as acne vulgaris (AV) - a common skin condition caused by Propionibacterium acnes - urinary tract infections (UTIs), respiratory infections like cystic fibrosis, and more.
Biomx's team of scientists and researchers are dedicated to advancing the field of phage therapy and improving patient outcomes. The company has partnerships with leading academic institutions, hospitals, and pharmaceutical companies to accelerate the development of its technology platform.
In conclusion, Biomx Ltd is a biotechnology company that is revolutionizing the fight against chronic diseases with natural and engineered phage therapies. Its innovative approach to personalized medicine has shown promising results in preclinical studies for IBD and other applications. With a dedicated team of scientists and partnerships with leading institutions, Biomx is poised to make a significant impact on the healthcare industry in the years to come.
biomx.com